Celltrion Pharm Inc.

South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...

EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...

As South Korean securities regulators are moving to tighten their grip on the growing trend of splitting up businesses and listing the spun-off arms...

South Korea’s major companies are showcasing robots, mobility and the metaverse rather than cutting-edge models of their conventional products...

A Korean startup about a year old has succeeded in creating a microchip that speeds up trading by a few microseconds -- a huge difference in the w...

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

South Korea’s corporate sector has seen record deals through mergers and acquisitions, tie-ups and spin-offs this year, as big companies and s...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Hopes for improving corporate earnings are rising as countries around the world are relaxing their anti-COVID-19 measures, but South Korean companie...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...

SK Inc., the holding and investment company of South Korea’s SK Group, plans to invest 120 billion won ($102 million) in China’s Lingbao...

South Korean companies are emerging as big buyers in the global mergers and acquisitions (M&A) markets. They are actively looking for future gro...

SK Inc., the investment arm of South Korean conglomerate SK Group, and private equity firm STIC Investment Inc., have invested a combined 65 billion...

South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...

Investors are selling technology stocks in a major Asian economy on regulatory worries just as one of the country’s biggest online payment com...

South Korean software and ICT conglomerate Hancom Group will be the first private company in the country to launch a micro-satellite, or a satellite...

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

South Korea’s major companies are rushing to secure cash to fund new business. Some have sold or securitized property, while others issued n...

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...

JW Pharmaceutical Co. has become the first South Korean drug maker to develop the generic version of a next-generation antibiotic substance, the med...

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...

"When life gets too hard, this is the pharmaceutical company stock you must buy," advises the title of Hanwha Securities' recent research note on Wh...

South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...

Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...

South Korea’s major companies are sitting on a record amount of cash reserves, setting the foundation for the merger and acquisition (M&A)...

South Korea's Celltrion Inc. has completed second-phase clinical trials of its COVID-19 treatment and is seeking conditional approval of its distr...